A Modeling and Simulations Framework to Support Global Regulatory Strategies for Pediatric Drug Development Programs

Area of Science:

• Pharmacometrics and Computational Toxicology
• Pediatric Drug Development and Regulatory Science

Background:

• Pediatric drug development requires global strategies aligning with FDA and EMA legislation.
• Current regulations necessitate integrated Pediatric Investigation Plans (PIP) and Pediatric Study Plans (PSP).

Purpose of the Study:

• To propose a pharmacometrics framework supporting global regulatory strategies for pediatric drug development.
• To identify opportunities for applying modeling and simulation in designing PIP and PSP.

Main Methods:

• Development of a pharmacometrics framework outlining trigger points for simulation application.
• Integration of modeling and simulation techniques into the design of PIP and PSP.

Main Results:

• The proposed framework identifies critical points for utilizing simulations in pediatric drug development.
• Simulation-driven protocol development enhances clarity and success probability for global programs.

Conclusions:

• Pharmacometrics modeling and simulation are crucial for optimizing pediatric drug development programs.
• This approach leads to more efficient, less failure-prone, and cost-effective clinical trial designs.